Anavex Life Sciences Corp. (0HFR.L)

USD 9.08

(-3.55%)

Gross Profit Summary of Anavex Life Sciences Corp.

  • Anavex Life Sciences Corp.'s latest annual gross profit in 2023 was - USD , down 0.0% from previous year.
  • Anavex Life Sciences Corp.'s latest quarterly gross profit in 2024 Q3 was - USD , down 0.0% from previous quarter.
  • Anavex Life Sciences Corp. reported a annual gross profit of - USD in annual gross profit 2022, down 0.0% from previous year.
  • Anavex Life Sciences Corp. reported a annual gross profit of - USD in annual gross profit 2021, down 0.0% from previous year.
  • Anavex Life Sciences Corp. reported a quarterly gross profit of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Anavex Life Sciences Corp. reported a quarterly gross profit of - USD for 2024 Q3, down 0.0% from previous quarter.

Annual Gross Profit Chart of Anavex Life Sciences Corp. (2023 - 2004)

Historical Annual Gross Profit of Anavex Life Sciences Corp. (2023 - 2004)

Year Gross Profit Gross Profit Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 100.0%
2016 -1252.00 USD 0.0%
2015 - USD 0.0%
2014 - USD 100.0%
2013 -12 Thousand USD 0.0%
2012 - USD 100.0%
2011 -63.11 Thousand USD -392.66%
2010 -12.81 Thousand USD 0.0%
2009 - USD 100.0%
2008 -75 Thousand USD -7.14%
2007 -70 Thousand USD -9233.33%
2006 -750.00 USD 75.0%
2005 -3000.00 USD 0.0%
2004 - USD 0.0%

Peer Gross Profit Comparison of Anavex Life Sciences Corp.

Name Gross Profit Gross Profit Difference
Editas Medicine, Inc. -99.52 Million USD 100.0%
Dynavax Technologies Corporation 182.11 Million USD 100.0%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 100.0%
Perrigo Company plc 1.68 Billion USD 100.0%
Illumina, Inc. 2.74 Billion USD 100.0%
Thermo Fisher Scientific Inc. 15.22 Billion USD 100.0%
Iovance Biotherapeutics, Inc. -9.56 Million USD 100.0%
Walgreens Boots Alliance, Inc. 26.52 Billion USD 100.0%
IQVIA Holdings Inc. 5.23 Billion USD 100.0%
Heron Therapeutics, Inc. 10.04 Million USD 100.0%
Regeneron Pharmaceuticals, Inc. 11.3 Billion USD 100.0%
Unity Biotechnology, Inc. -19.69 Million USD 100.0%
Waters Corporation 1.76 Billion USD 100.0%
Biogen Inc. 7.3 Billion USD 100.0%
Sangamo Therapeutics, Inc. -45.32 Million USD 100.0%
Evolus, Inc. 140.52 Million USD 100.0%
Adicet Bio, Inc. -6.09 Million USD 100.0%
Cara Therapeutics, Inc. 14.79 Million USD 100.0%
bluebird bio, Inc. -4.03 Million USD 100.0%
Esperion Therapeutics, Inc. 73.06 Million USD 100.0%
FibroGen, Inc. 128.9 Million USD 100.0%
Agilent Technologies, Inc. 3.46 Billion USD 100.0%
Corbus Pharmaceuticals Holdings, Inc. -31.16 Million USD 100.0%
Homology Medicines, Inc. -7.22 Million USD 100.0%
Geron Corporation -123.5 Million USD 100.0%
Alnylam Pharmaceuticals, Inc. 1.51 Billion USD 100.0%
Amicus Therapeutics, Inc. 362.03 Million USD 100.0%
Myriad Genetics, Inc. 476.4 Million USD 100.0%
Viking Therapeutics, Inc. -292 Thousand USD 100.0%
Intellia Therapeutics, Inc. -398.79 Million USD 100.0%
Zoetis Inc. 5.83 Billion USD 100.0%
Abeona Therapeutics Inc. 302 Thousand USD 100.0%
Mettler-Toledo International Inc. 2.16 Billion USD 100.0%
BioMarin Pharmaceutical Inc. 1.9 Billion USD 100.0%
Vertex Pharmaceuticals Incorporated 8.6 Billion USD 100.0%
Kala Pharmaceuticals, Inc. -303 Thousand USD 100.0%
Ionis Pharmaceuticals, Inc. 778.51 Million USD 100.0%
Atara Biotherapeutics, Inc. -313 Thousand USD 100.0%
Verastem, Inc. -62 Thousand USD 100.0%
Nektar Therapeutics 53.47 Million USD 100.0%
Axsome Therapeutics, Inc. 244.53 Million USD 100.0%
Aclaris Therapeutics, Inc. -85.21 Million USD 100.0%
Sarepta Therapeutics, Inc. 1.09 Billion USD 100.0%
OPKO Health, Inc. 318.12 Million USD 100.0%
Exelixis, Inc. 1.75 Billion USD 100.0%
Neurocrine Biosciences, Inc. 1.84 Billion USD 100.0%
Corcept Therapeutics Incorporated 475.89 Million USD 100.0%
uniQure N.V. 2.21 Million USD 100.0%
Imunon, Inc. -720 Thousand USD 100.0%
Blueprint Medicines Corporation 236.58 Million USD 100.0%
Insmed Incorporated 239.63 Million USD 100.0%
Halozyme Therapeutics, Inc. 636.89 Million USD 100.0%
Agios Pharmaceuticals, Inc. 17.31 Million USD 100.0%
TG Therapeutics, Inc. 219.1 Million USD 100.0%
Incyte Corporation 3.44 Billion USD 100.0%
Emergent BioSolutions Inc. 343.9 Million USD 100.0%